###### Key messages

What is the key question?
=========================

-   What are the effects of pulmonary endarterectomy (PEA) on pulmonary vascular resistance and compliance in chronic thromboembolic pulmonary hypertension (CTEPH), and what is the prognostic impact of these effects?

What is the bottom line?
========================

-   Postoperative pulmonary vascular resistance assessed in the intensive care unit is a strong predictor of long-term survival/freedom of lung transplantation in patients with CTEPH undergoing PEA.

Why read on?
============

-   This is the first prospective longitudinal study confirming a correlation among characteristics of the surgical specimen, haemodynamics and long-term right ventricular recovery in patients with CTEPH undergoing PEA.

Introduction {#s1}
============

Pulmonary endarterectomy (PEA) is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH)[@R1] with a periprocedural mortality rate of \<5% in Europe today,[@R2] nearly normalised haemodynamics and substantial improvement in clinical symptoms in the majority of patients.[@R1] Outcomes after PEA have been estimated on the basis of postoperative pulmonary vascular resistance (PVR) measurements, with a PVR of 500 dynes.s.cm^−5^ as a threshold of favourable outcome in several databases.[@R1] [@R2] Right ventricular (RV) afterload bears a steady component (represented by PVR) and an oscillatory component (the opposition that the ventricle encounters to maintain forward flow and pulsatile components of flow). Pulmonary arterial compliance (C~PA~) relates to oscillatory load with potentially greater prognostic importance than resistance.[@R5] [@R6] RV hydraulic load is determined by the dynamic interaction between PVR and C~PA.~[@R7] The product of resistance (PVR) and C~PA~ is consistently inversely related and remains unaltered at approximately 0.7 s in various types of pulmonary hypertension (PH).[@R8] We have recently reported that patients with persistent exertional dyspnoea after successful PEA display an abnormal pulmonary haemodynamic response to exercise, characterised by increased PVR and decreased C~PA.~[@R7] Because PEA mainly affects major vessels that are surgically accessible, and C~PA~ appears to be determined by the larger vessel compartment,[@R9] we hypothesised that PEA primarily increases C~PA,~ which may then also be an important predictor of prognosis in CTEPH. Therefore, we quantified thrombus, measured the impact of PEA on haemodynamics in a 'structure/function' study and analysed which RV afterload parameter (PVR, C~PA~ or resistance times compliance (RC-time)) is the best predictor of long-term survival/freedom of lung transplantation in an outcome study.

Methods {#s2}
=======

Patients and clinical assessments {#s2a}
---------------------------------

The study was carried out at the Pulmonary Hypertension Unit, Vienna General Hospital, a national referral centre for CTEPH in Austria. Diagnosis of CTEPH, criteria for PEA and surgical procedures were based on previously published standards.[@R10] [@R11] Patients undergoing bilateral PEA at our institution were included in the study and were followed for 34.5 (11.9; 78.3) months.

Right heart catheterisation (RHC) was obtained on three occasions: at baseline, within 4 days after PEA in the intensive care unit prior to removal of the intraoperative Swan-Ganz and left atrial catheters ('immediate postoperative') when patients were off vasopressors, and 1 year after PEA ('1-year follow-up (FU)'). During baseline catheterisation, left ventricular end-diastolic pressures were measured to validate wedge pressures. During PEA, a left atrial catheter was inserted intrapericardially via the right upper lobe vein in the left atrium, and out through the skin under the right costal arch. The catheter allowed post-PEA measurements of left atrial pressures. The catheter was pulled within a few hours and a maximum of 4 days, after a final haemodynamic measurement. After the 1-year FU, patients were seen on a yearly basis as outpatients. Additional RHCs were indicated on the basis of clinical signs and symptoms.

Haemodynamic definitions {#s2b}
------------------------

PVR was calculated by mean pulmonary arterial pressure (mPAP)---mean pulmonary capillary wedge pressure/cardiac output (CO) multiplied by 80 for dynes.s.cm^−5^.

C~PA~ was calculated as stroke volume (CO/heart rate) divided by systolic PAP---diastolic PAP. The RC-time (product of resistance (R=PVR) and compliance (C~PA~)) was calculated as previously described[@R8] and expressed in seconds.

Persistent/recurrent PH was defined as mPAP≥25 mmHg and PVR≥400 dynes.s.cm^−5^ at the routine 1-year FU RHC.[@R11]

Analysis of PEA specimens {#s2c}
-------------------------

The Jamieson classification system[@R3] was used to describe the four major types of CTEPH. Jamieson type I is semiorganised or organised thrombus that begins in the main or lobar arteries; type II is organised thrombus and intimal thickening proximal to segmental arteries; type III is intimal thickening and fibrosis in the distal segmental arteries; and type IV is distal arteriolar vasculopathy with no intraluminal disease. If there was a discrepancy in CTEPH type between left and right specimen, the most proximal thrombus determined the final classification.

Starting 2005, semiquantitative assessment of consecutive PEA specimens, labelled as 'thrombi', was performed. Thrombi were laid out, weighed and photographed (n=69). Organised small-vessel thrombus ('thrombus tails') was defined as white dissectate, \<2 mm in thickness and at least 2 mm in length. Thrombus tails were counted and measured in centimetres. Those analysing PEA specimens (GM and CG) were blinded to haemodynamic data.

Statistical analysis {#s2d}
--------------------

Continuous parameters were summarised by means±SDs, or in the case of skewed distributions, by medians (25% percentile; 75% percentile). Discrete data were presented as counts. Deltas (Δs) were calculated as the difference between values at the immediate postoperative RHC and baseline RHC, and were depicted as vectors for each patient.

Disease-specific survival was defined as freedom from lung transplantation or death from right heart failure, which was defined as death in the intensive care unit under the signs of RV pump failure, or was based on an autopsy report and written confirmation by the primary care physician if the patient died outside of the hospital. For comparisons, t tests were performed using the Bonferroni correction. The impact of haemodynamic parameters and thrombus characteristics on survival and PH recurrence was analysed by Cox proportional hazard models and logistic regression models. Models were adjusted for age, sex and baseline PVR. All tests regarding the hazard rate were subjected to Bonferroni correction. Time dependent receiver operator characteristic curves (ROC) at 1, 3 and 5 years were plotted for all risk factors, which were significant (α=0.05) in the Cox models, using the R package 'pROC'[@R12] to determine area under the curve, specificity and sensitivity of the optimal cut-offs (according to Youden\'s index). Regarding the outcome variable status, Kaplan--Meier-survival curves were plotted.

In addition, Fisher\'s exact tests were calculated for baseline PVR\>1000 dynes.s.cm^−5^ as predictor of survival. Spearman correlation coefficients among change of C~PA~, immediate postoperative PVR and thrombus size (ie, the total number of thrombus tails and their total length per patient) were calculated. p Values below 0.05 were considered statistically significant. The statistical computing environment R V.2.13.1 was used.[@R13]

The Ethics Committee of the Medical University of Vienna approved the study, and participating patients signed informed consents.

Results {#s3}
=======

Baseline characteristics {#s3a}
------------------------

A total of 110 patients undergoing PEA between May 1994 and December 2010 were included in the study. Patients' baseline characteristics are summarised in [table 1](#THORAXJNL2013203746TB1){ref-type="table"}.

###### 

Baseline patient characteristics

  --------------------------------------------------------------------
                                                          n\
                                                          110 (100%)
  ------------------------------------------------------- ------------
  Age (years)                                             56±14

  Gender (f/m)                                            56/54

  BMI                                                     26 ± 4

  WHO functional class (II/III/IV)                        5/76/29

  6-MWD (m)                                               390 ± 119

  Time from first symptoms to diagnosis (months)          26 ± 36

  Time to PEA (days)                                      129 ± 362

  Medical treatment prior to PEA (n=number of patients)   5 (0.05)

  CTEPH types I/II/III/IV                                 32/55/15/8
  --------------------------------------------------------------------

The data are presented as means ± SD. Discrete data are presented as counts.

6-MWD, 6-min walking distance; BMI, body mass index; CTEPH, chronic thromboembolic pulmonary hypertension; PEA, pulmonary endarterectomy.

All patients were on standard medical therapy consisting of oral anticoagulation (international normalised ratio 2.0--3.0), digitalis, diuretics and other supportive treatments including birth control and vaccinations. Five patients who were referred from other centres received preoperative pulmonary arterial hypertension (PAH)-specific therapies (sildenafil, bosentan, inhaled iloprost) that were terminated at the time of PEA. Patients underwent surgery 129±362 days after diagnosis. CTEPH types[@R3] are listed in [table 1](#THORAXJNL2013203746TB1){ref-type="table"}.

Analysis of PEA specimens {#s3b}
-------------------------

In all, 11±3 thrombus tails were counted per surgical specimen, measuring 19±5 cm in total length. [Figure 1](#THORAXJNL2013203746F1){ref-type="fig"} shows two representative examples of surgical specimen analyses. Total numbers and lengths of thrombus tails were inversely correlated with immediate postoperative PVR (r=−0.58, p\<0.0001; r=−0.57, p\<0.0001; [figure 2](#THORAXJNL2013203746F2){ref-type="fig"}A,B) and Δ C~PA~ (from baseline to immediately postoperative, r=0.44, p=0.002; and to 1 year FU, r=0.44, p=0.002). Thrombus weights varied widely and did not correlate with haemodynamic parameters (data not shown).

![Illustration of how numbers and lengths of tails were accounted for. Tails were defined as dissectates not exceeding 2 mm in thickness and at least 2 mm in length (measured tails in this specimen are pointed out by white double-headed arrows). For the analysis, thrombus tails were counted and their total length was expressed in centimetres. The following two examples represent a 'good' (A) and a 'poor' (B) surgical specimen. (A) Surgical specimen of patient \#101 with an immediate postoperative pulmonary vascular resistance (PVR) of 190 dynes.s.cm^−5^ and 19 thrombus tails (total tail length 24.5 cm). (B) Surgical specimen of patient \#14 with an immediate postoperative PVR of 640 dynes.s.cm^−5^ and only four thrombus tails (total tail length 8.1 cm).](thoraxjnl-2013-203746f01){#THORAXJNL2013203746F1}

![Scatter plots of immediate postoperative pulmonary vascular resistance (PVR) against the cumulative length of surgically extracted thrombus tails in centimetres (p\<0.0001, r=−0.566 (A)) and against the cumulative number of surgically extracted thrombus tails (p\<0.0001, r=−0.580 (B)).](thoraxjnl-2013-203746f02){#THORAXJNL2013203746F2}

Haemodynamic changes as a consequence of PEA {#s3c}
--------------------------------------------

Haemodynamic assessment within 4 days after PEA (2±2 days) was performed in 104 patients, with left atrial pressures serving to assess postoperative PVRs. The remaining six patients are \#19, \#22, \#42, \#43 (operated in 1996), \#72 (operated in 2004) and \#81. Immediate postoperative data of these patients were not available because left atrial catheters were pulled before a final haemodynamic evaluation.

Haemodynamic parameters at baseline, immediate postoperative and at 1-year FU are listed in [table 2](#THORAXJNL2013203746TB2){ref-type="table"}.

###### 

Haemodynamic parameters assessed at baseline, immediate postoperative and at 1-year follow-up

  ---------------------------------------------------------------------------------------------
                         Baseline\         Immediate postoperative n=104   1-year FU\
                         n=110                                             n=71
  ---------------------- ----------------- ------------------------------- --------------------
  PVR (dynes.s.cm^−5^)   770 (583; 1011)   368 (251; 516)\*\*              280 (186; 472)\*\*

  C~PA~ (mL/mm Hg)       1.0 (0.8; 1.4)    2.2 (1.5; 3.2)\*\*              2.7 (1.4; 3.8)\*\*

  RC-time(s)             0.72±0.71         0.60±0.3                        0.59±0.34

  SV (mL)                58.4±16.8         61.1±20.9                       71.6±18.6 \*\*
  ---------------------------------------------------------------------------------------------

PVR and C~PA~ are presented as medians (25% percentile; 75% percentile), RC-time and SV as means±SDs.

\*\*p\<0.001.

C~PA~, pulmonary arterial compliance; FU, follow-up; PVR, pulmonary vascular resistance; RC-time, resistance times compliance; SV, stroke volume.

### PVR, C~PA~, RC-time and stroke volume {#s3c1}

PVR decreased from preoperative 770.4 (583; 1011) to 368 (251; 516) dynes.s.cm^−5^ immediate postoperative (p\<0.001, [figure 3](#THORAXJNL2013203746F3){ref-type="fig"}A). The change of PVR between immediate postoperative and 1-year FU was not significant (p=0.22). C~PA~ changed significantly from baseline to immediate postoperative, without further changes to 1-year FU ([figure 3](#THORAXJNL2013203746F3){ref-type="fig"}B). On average, RC-time decreased after PEA, albeit not significantly: RC-time=0.72±0.71 s (baseline), RC-time=0.60±0.3 s (immediate postoperative) and RC-time=0.59±0.34 s (1-year FU; [figure 3](#THORAXJNL2013203746F3){ref-type="fig"}C; paired t test: p=0.13 from baseline to immediate postoperative, and p=0.32 from baseline to 1-year FU). The change of RC-time was not different between patients with persistent/recurrent PH compared with patients with no PH (immediately postoperative p=0.81, at 1 year p=0.64).

![Box plots of steady and pulsatile flow parameters at baseline, immediately postoperative and at 1-year follow-up (FU). (A) Pulmonary vascular resistance (PVR) decreased from preoperative 770.4 (583.2; 1011) to 368.5 (250.5; 516) immediately postoperative, and to 280 (186.3; 472) dynes.s.cm^−5^ at 1-year FU (p\<0.001, p\<0.001, ie, respective changes from baseline). (B) Pulmonary arterial compliance (C~PA~) changed from 1.0 (0.8; 1.4) to 2.1 (1.5; 3.2) immediately postoperative, and to 2.7 (1.4; 3.8) mL/mm Hg at 1-year FU (p\<0.001 and p\<0.001). (C) Resistance times compliance (RC-time) did not change significantly during the observation period: RC-time=0.72+0.71 s (baseline), RC-time=0.60+0.3 s (immediately postoperatively) and RC-time=0.59+0.34 s (1-year FU; p=0.13 and p=0.32). (D) Stroke volume (SV) increased from preoperative 58.4±16.8 to 61.1±20.9 immediately postoperative and to 71.6±18.6 mL at 1-year FU (p=NS and p\<0.001).](thoraxjnl-2013-203746f03){#THORAXJNL2013203746F3}

Stroke volume increased from baseline to 1-year FU, while it did not change significantly from baseline to immediate postoperative ([figure 3](#THORAXJNL2013203746F3){ref-type="fig"}D).

### Vector diagram indicating the change in both R and C between catheterisations {#s3c2}

[Figure 4](#THORAXJNL2013203746F4){ref-type="fig"} depicts vectors from the origin that indicate the change (Δ) in both PVR and C~PA~ between catheterisations at baseline and immediate postoperative to discriminate poor 'PVR-responders' from poor 'C~PA~-responders'. The majority of vectors (n=78, 75%) point to the top-left quadrant indicating that if PVR decreases, C~PA~ increases concordantly. The five vectors ending in the top-right quadrant ('PVR non-responders') represent five patients with persistent/recurrent PH, with one patient dying from right heart failure. In the left-bottom quadrant (concordant decreases of PVR and C~PA~) are 21 vectors representing predominantly female patients, of whom 14 patients (67%) had persistent/recurrent PH, with seven deaths (33%). In this group were three patients with ventriculo-atrial (VA) shunts (out of a total of four patients with (VA) shunts among the 110 patients).

![Δ Pulmonary vascular resistance (PVR) and Δ pulmonary arterial compliance (C~PA~) represented as vectors from the origin, indicating changes in both PVR and C~PA~ between catheterisations at baseline and immediately postoperative. All patients' vectors with persistent/recurrent pulmonary hypertension (PH) in the left-upper quadrant are localised within the circled area (representing cases with only a minor improvement in C~PA~ and PVR).](thoraxjnl-2013-203746f04){#THORAXJNL2013203746F4}

Survival {#s3d}
--------

Overall survival showed 1-, 3- and 5-year cumulative rates of 92%, 89%, 85% and 61% at 10 years.

Perioperative inhospital death occurred in five patients (three female patients, 5%) at 11±14 days after PEA ([table 3](#THORAXJNL2013203746TB3){ref-type="table"}) due to right heart failure. Deceased patients had higher baseline PVRs (1090±502 dynes.s.cm^−5^) and higher immediate postoperative PVRs (821±501 dynes.s.cm^−5^). Three further patients died within the first year (163±117 days postoperatively). Mean immediate postoperative PVR was 587±147 dynes.s.cm^−5^ in these cases.

###### 

Haemodynamic variables of patients with early mortality (within 31 days after PEA), at baseline and immediately postoperative

                         Baseline     Immediately postoperative
  ---------------------- ------------ ---------------------------
  PVR (dynes.s.cm^−5^)   1090 ± 502   821±254
  C~PA~ (mL/mm Hg)       0.92 ± 0.3   1.5±1.5
  SV (mL)                44.6±16.7    40.6±27

The data are presented as means±SDs.

C~PA~, pulmonary arterial compliance; PEA, pulmonary endarterectomy; PVR, pulmonary vascular resistance; SV, stroke volume.

Predictors of outcome {#s3e}
---------------------

During the observation 21 events occurred. Two patients died from malignancies and were excluded from the analyses of disease-specific survival.

Baseline PVR\>1000 dynes.s.cm^−5^ was a weak predictor of 1-, and 3- year survival (Fisher\'s exact test p=0.05, p=0.06).

In all, 28 patients (26%) had a PVR\>1000 dynes.s.cm^−5^ and a high risk for postoperative mortality.[@R1] Of these, eight patients (29%) died within the observation period, with immediate postoperative PVRs of 765±237 dynes.s.cm^−5^.

Cox regression analysis revealed immediate postoperative PVR as the strongest independent predictor of long-term survival/freedom of lung transplantation (HR 1.005; 95%, HR confidence limits 1.003 to 1.006; p\<0.0001). Immediate postoperative PVR≥590 dynes.s.cm^−5^ can predict death/lung transplantation in patients after PEA ([figure 5](#THORAXJNL2013203746F5){ref-type="fig"}).

![Receiver operator characteristics curve identifying an immediate postoperative pulmonary vascular resistance (PVR) of 590 dynes.s.cm^−5^ as the PVR threshold with greatest areas under the curve for likelihood of survival at 1, 3 and 5-year follow-ups.](thoraxjnl-2013-203746f05){#THORAXJNL2013203746F5}

Patients with immediate postoperative PVR\<590 dynes.s.cm^−5^ had a better long-term outcome than patients with PVR≥590 dynes.s.cm^−5^ (p\<0.0001; [figure 6](#THORAXJNL2013203746F6){ref-type="fig"}A). The absolute value of immediately postoperative PVR predicted survival. Patients with immediate postoperative PVR\<290 dynes.s.cm^−5^ had a better survival than patients with PVR between 292 and 450 dynes.s.cm^−5^, and those with immediate postoperative PVR\>450 dynes.s.cm^−5^ ([figure 6](#THORAXJNL2013203746F6){ref-type="fig"}B). None of the patients with an immediate postoperative PVR\<290 dynes.s.cm^−5^ died or underwent lung transplantation within the observation period.

![(A) Kaplan--Meier survival curves in patients with operated chronic thromboembolic pulmonary hypertension (CTEPH) and immediate postoperative pulmonary vascular resistance (PVR)≥590 dynes.s.cm^−5^ compared with patients with immediate postoperative PVR\<590 dynes.s.cm^−5^. Patients with immediate postoperative PVR\<590 dynes.s.cm^−5^ had a better long-term outcome than patients with PVR≥590 dynes.s.cm^−5^ (p\<0.0001). (B) Kaplan--Meier survival curves in patients with operated CTEPH by tertiles of immediate PVR (p\<0.001, respectively).](thoraxjnl-2013-203746f06){#THORAXJNL2013203746F6}

The numbers and lengths of thrombus tails were predictors of survival/freedom of lung transplantation (HR 0.81, p=0.02; HR 0.9; p=0.01, respectively).

Neither C~PA~ nor RC-time showed a significant influence on survival.

Predictors of persistent/recurrent PH {#s3f}
-------------------------------------

No baseline haemodynamic parameter, but only immediate postoperative PVR (HR 1.004; 95%, HR confidence limits: 1.0032 to 1.0056; p\<0.0001) was an independent predictor of persistent/recurrent PH.

The numbers and lengths of thrombus tails were predictors of persistent/recurrent PH (n=25; Log OR 0.74, p=0.0026; Log OR 0.86, p=0.002, respectively).

Discussion {#s4}
==========

Our data show that (i) PEA immediately decreased PVR and increased C~PA~, under a constant RC-time. However, (ii) immediate postoperative PVR was the only predictor of long-term survival/freedom of lung transplantation and (iii) patients from whom more and longer thrombus tails were removed had better postoperative haemodynamics and were less likely to develop persistent/recurrent PH. The outcome of operable CTEPH is best predicted immediately after PEA.

PVR and C~PA~ in patients with CTEPH are determined by major-vessel thromboembolic obstruction, small-vessel arteriopathy, right-heart function and CO.[@R14] Our structure/function study illustrated that the number of small thrombus tails determines normalisation of PVR after successful PEA, thus impacting short-term and long-term mortality.[@R1] Specimen assessment takes into account both the technical success of PEA and anatomical CTEPH type that has previously been correlated with outcomes.[@R15] In contrast to the systemic arterial system where compliance is mainly located in the proximal aorta, compliance of the pulmonary arterial tree in CTEPH is less well studied.[@R16]^--^[@R18] C~PA~ reflects pulsatile load of the right ventricle and appears to be mainly determined by large vessels.[@R9] In contrast to our study, Mahapatra *et al*[@R6] showed that invasively assessed C~PA~ is a strong predictor of survival in patients with idiopathic PAH (iPAH). In our patients, mean C~PA~ was lower (1.0 (0.8; 1.4) mL/mm Hg) than in the iPAH cases of Mahapatra *et al* (1.43±0.73 (range 0.40--3.77)mL/mm Hg).[@R9]

Based on our data, one could hypothesise that an important component of C~PA~ is located in surgically accessible pulmonary arteries in a majority of patients represented in the upper left quadrant of [figure 4](#THORAXJNL2013203746F4){ref-type="fig"}. The relationship between PVR and C~PA~ is hyperbolic, with a proportionally more important decrease of C~PA~ at close to normal PVR, and little further decrease of C~PA~ in severe PH. The RC-time, which describes the exponential decay of the PAP during diastole, was 0.72 at baseline, slightly higher than previously reported in a smaller population of CTEPH patients (0.49 s).[@R16] The product of PVR and C~PA~ did not change ([figure 3](#THORAXJNL2013203746F3){ref-type="fig"}A--C) which is in concordance with findings of patients under PAH-specific treatments.[@R8] [@R9] Searching for cases in whom proximal compliance improved more than resistance, we chose to represent individual cases as vectors from the origin. The majority of vectors point to the top-left quadrant confirming that if PVR decreases, C~PA~ increases concordantly, indicating a significant contribution of major vessel disobliteration to the improvement of vascular compliance in CTEPH. Those patients in whom PVR and C~PA~ are dissociated appear to experience worse outcomes (100% persistent/recurrent PH in the right upper quadrant of [figure 4](#THORAXJNL2013203746F4){ref-type="fig"}, and 67% persistent/recurrent PH in the left lower quadrant of [figure 4](#THORAXJNL2013203746F4){ref-type="fig"}). Causes may be a stiff and obstructed distal microcirculatory compartment or residual thrombus.

In the outcome study we analysed the effects of haemodynamic changes on long-term survival/freedom of lung transplantation. CTEPH is a dual vascular disorder, with a major vessel disease component that can be addressed by surgical PEA as well as a microvascular disease (secondary vasculopathy). Secondary vasculopathy of CTEPH is indistinguishable from pulmonary vascular lesions seen in PAH[@R19] and affects pulmonary arteries measuring less than 200 µm in diameter, contributing to higher PVR and increased postoperative mortality. It has been difficult to compartmentalise resistance prior to PEA, that is, to predict which proportion of PVR is due to major vessel obstruction and which is due to small vessel disease.[@R20] [@R21] A preoperative PVR above 1000 dynes.s.cm^−5^ has generally been labelled as an important clinical risk factor, underlying a mortality rate of 10.1%,[@R1] and is possibly a marker for significant small vessel disease. In the international prospective CTEPH registry,[@R2] patients presenting with baseline PVR between 800 and 1000 dynes.s.cm^−5^ had mortality rates (inhospital and 1-year) of 14.4% (15 of 104 patients), while patients with PVR\>1200 dynes.s.cm^−5^ had mortality rates of 23.4%. While a baseline PVR\>1000 dynes.s.cm^−5^ was a weak predictor of survival, preoperative PVR as a continuous variable did not appear as a multivariate predictor of 1-year-survival, similar to what was seen in the CTEPH registry.[@R2] Furthermore, more recent studies have documented a significant reduction in post-PEA mortality even in patients with PVR\>1000 dynes.s.cm^−5^ at baseline.[@R4] By contrast, PVR measured immediately postoperative[@R11] had a significant influence on long-term outcome (p\<0.0001), at a threshold of 590 dynes.s.cm^−5^. Similar cut-offs (500 dynes.s.cm^−5^) were predictive of 30-day outcomes (p\<0.001) in the study by Jamieson and coworkers.[@R1] Our data demonstrate that patients with immediate postoperative PVR\<290 dynes.s.cm^−5^ had excellent outcomes beyond 10 years FU.

Limitations {#s4a}
-----------

The relatively small study size and the single-centre design count as limitations. In addition, PEA specimens were not available from all patients and assessments were semiquantitative. Outcomes were influenced by a centre-specific 'learning curve' that is significant in this technically difficult surgical procedure. Furthermore, we did not systematically assess residual thrombus by postoperative imaging.

Conclusions {#s5}
===========

The data support the value of a complete and bilateral surgical endarterectomy, and the need for a final haemodynamic assessment in the intensive care unit prior to removal of the Swan-Ganz catheter to assess postoperative PVR. PVR is the key haemodynamic parameter for predicting prognosis in CTEPH patients undergoing PEA. The outcome of operable CTEPH is best predicted immediately after PEA, based on PVR and the characteristics of the surgical specimen.
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